Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002081463 | SCV002421855 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004046425 | SCV003715921 | uncertain significance | not specified | 2021-12-21 | criteria provided, single submitter | clinical testing | The c.316G>C (p.D106H) alteration is located in exon 3 (coding exon 3) of the DEF6 gene. This alteration results from a G to C substitution at nucleotide position 316, causing the aspartic acid (D) at amino acid position 106 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |